News Digest / Ticker: IKT

Ticker: IKT

06:00pm, Wednesday, May 14, 2025

Inhibikase Therapeutics Reports $13.7M Net Loss Amid Rising R&D Costs and Liquidity Improvements

Inhibikase Therapeutics, Inc. (NASDAQ: IKT) has released its quarterly report for the period ending March 31, 2025, detailing its financial status and operational developments. Here are the key highlights: Income Statement Overview: Total revenues for the quarter were $0, a consistent trend fro...